Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14K Sell
15,997
-31,489
-66% -$29.7K ﹤0.01% 3604
2025
Q4
$47K Buy
+47,486
New +$59K ﹤0.01% 2882
2025
Q3
Sell
-43,530
Closed -$34K 3223
2025
Q2
$34K Buy
43,530
+32,806
+306% +$38.8K ﹤0.01% 2353
2025
Q1
$10K Buy
+10,724
New +$20.2K ﹤0.01% 2353

Other funds holding IFRX

HRT Financial's IFRX Position: Q1 2026 in Review

HRT Financial reduced its InflaRx (IFRX) stake by 66% in Q1 2026, selling an estimated $29.7K and leaving 15,997 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #3604.

HRT Financial first reported a position in IFRX in Q1 2025 and has held it in 4 quarters since. The position peaked at $47K in Q4 2025. 35 funds tracked by Wall St. Rank hold IFRX as of Q1 2026.

  • HRT Financial held 15,997 shares of InflaRx worth $14K as of Q1 2026.
  • HRT Financial sold 31,489 InflaRx shares in Q1 2026, an estimated $29.7K.
  • InflaRx made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3604 holding.
  • HRT Financial first reported a position in InflaRx in Q1 2025 and has held it in 4 quarters since.
  • HRT Financial's InflaRx position peaked at $47K in Q4 2025.
  • 35 funds tracked by Wall St. Rank held InflaRx as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.